Erudio Healtherudio.com
Sponsor
Royal Marsden NHS Foundation Trust trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by Royal Marsden NHS Foundation Trust: DESTINATION 2. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 3 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (Royal Marsden NHS Foundation Trust). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| DESTINATION 2 NCT06638541 · Royal Marsden NHS Foundation Trust | prostate cancer | Not applicable | 170 | 16 | Standard | Nov 16, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| PACE NCT01584258 · Royal Marsden NHS Foundation Trust DeepView → | organ-confined prostate cancer | Phase 3 | Deep | View | |||
| TRAK-ER NCT04985266 · Royal Marsden NHS Foundation Trust StandardView → | ER-positive HER2-negative breast cancer with molecular relapse | Phase 2 | Standard | View | |||
| POLEM NCT03827044 · Royal Marsden NHS Foundation Trust FocusedView → | stage III dMMR or POLE mutant colon cancer | Phase 3 | Focused | View | |||